Leishmania donovani pteridine reductase 1:: Biochemical properties and structure-mode ling studies

被引:32
作者
Kumar, Pranav [1 ]
Kumar, Ashutosh
Verma, Shyam Sundar
Dwivedi, Namrata
Singh, Nasib
Siddiqi, Mohammad Imran
Tripathi, Rama Pati
Dube, Anuradha
Singh, Neeloo [1 ,2 ]
机构
[1] Cent Drug Res Inst, Div Mol, POB 173, Lucknow 226001, Uttar Pradesh, India
[2] Cent Drug Res Inst, Div Struct Biol, Lucknow 226001, Uttar Pradesh, India
关键词
pteridine reductase 1; clinical isolate; recombinant protein; antileishmanial screening; flow cytometry; structural modeling; Leishmania donovani; antileishmanial drug screening;
D O I
10.1016/j.exppara.2008.05.005
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Pteridine reductase 1 (PTR1, EC 1.5.1.33) is a NADPH dependent short-chain reductase (SDR) responsible for the salvage of pterins in the protozoan parasite Leishmania. This enzyme acts as a metabolic bypass for drugs targeting dihydrofolate reductase, therefore, for successful antifolate chemotherapy to be developed against Leishmania, it must target both enzyme activities. Based on homology model drawn on recombinant pteridine reductase isolated from a clinical isolate of L. donovani, we carried out molecular modeling and docking studies with two compounds of dihydrofolate reductase specificity showing promising antileishmanial activity in vitro. Both the inhibitors appeared to fit well in the active pocket revealing the tight binding of the carboxylic acid ethyl ester group of pyridine moiety to pteridine reductase and identify the important interactions necessary to assist the structure based development of novel pteridine reductase inhibitors. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 34 条
[1]   PTR1 - A REDUCTASE MEDIATING SALVAGE OF OXIDIZED PTERIDINES AND METHOTREXATE RESISTANCE IN THE PROTOZOAN PARASITE LEISHMANIA-MAJOR [J].
BELLO, AR ;
NARE, B ;
FREEDMAN, D ;
HARDY, L ;
BEVERLEY, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11442-11446
[2]   LUDI - RULE-BASED AUTOMATIC DESIGN OF NEW SUBSTITUENTS FOR ENZYME-INHIBITOR LEADS [J].
BOHM, HJ .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (06) :593-606
[3]   Life in vacuoles -: nutrient acquisition by Leishmania amastigotes [J].
Burchmore, RJS ;
Barrett, MP .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2001, 31 (12) :1311-1320
[4]   DNA vaccination against the parasite enzyme gamma-glutamylcysteine synthetase confers protection against Leishmania donovani infection [J].
Carter, K. C. ;
Henriquez, F. L. ;
Campbell, S. A. ;
Roberts, C. W. ;
Nok, A. ;
Mullen, A. B. ;
McFarlane, E. .
VACCINE, 2007, 25 (22) :4502-4509
[5]   Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin [J].
Cunningham, ML ;
Titus, RG ;
Turco, SJ ;
Beverley, SM .
SCIENCE, 2001, 292 (5515) :285-287
[6]   Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis [J].
Dutta, A ;
Bandyopadhyay, S ;
Mandal, C ;
Chatterjee, M .
PARASITOLOGY INTERNATIONAL, 2005, 54 (02) :119-122
[7]   Tetrabutylammonium hydrogensulphate catalyzed efficient synthesis of glycosyl(aryl) dihydropyrimidinones [J].
Dwivedi, N ;
Mishra, RC ;
Tripathi, RP .
LETTERS IN ORGANIC CHEMISTRY, 2005, 2 (05) :450-457
[8]  
Gehlhaar D.K., 1999, Rational Drug Design: Novel Methodology and Practical Applications, VVol.719, P292, DOI [10.1021/BK-1999-0719.CH019, DOI 10.1021/BK-1999-0719.CH019]
[9]   MOLECULAR RECOGNITION OF THE INHIBITOR AG-1343 BY HIV-1 PROTEASE - CONFORMATIONALLY FLEXIBLE DOCKING BY EVOLUTIONARY PROGRAMMING [J].
GEHLHAAR, DK ;
VERKHIVKER, GM ;
REJTO, PA ;
SHERMAN, CJ ;
FOGEL, DB ;
FOGEL, LJ ;
FREER, ST .
CHEMISTRY & BIOLOGY, 1995, 2 (05) :317-324
[10]   Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites [J].
Gourley, DG ;
Schüttelkopf, AW ;
Leonard, GA ;
Luba, J ;
Hardy, LW ;
Beverley, SM ;
Hunter, WN .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (06) :521-525